Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Albany Molecular Research Company Profile (NASDAQ:AMRI)

Consensus Ratings for Albany Molecular Research (NASDAQ:AMRI) (?)
Ratings Breakdown: 1 Sell Rating(s), 1 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.25)
Consensus Price Target: $18.40 (14.36% upside)

Analysts' Ratings History for Albany Molecular Research (NASDAQ:AMRI)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/15/2014ZacksDowngradeOutperform -> Neutral$17.80ViewTweet This Rating  Share This Rating on StockTwits
4/11/2014ZacksUpgradeNeutral -> Outperform$17.00ViewTweet This Rating  Share This Rating on StockTwits
4/9/2014Morgan StanleyInitiated CoverageOverweight$19.00ViewTweet This Rating  Share This Rating on StockTwits
3/21/2014Sterne AgeeDowngradeNeutral -> UnderperformViewTweet This Rating  Share This Rating on StockTwits
3/5/2014TheStreetUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
12/3/2013Sterne AgeeDowngradeBuy -> Neutral$15.00 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
11/8/2013TheStreetUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
8/13/2013Sterne AgeeLower Price TargetBuy$15.00 -> $14.00ViewTweet This Rating  Share This Rating on StockTwits
6/11/2013Sterne AgeeInitiated CoverageBuy$15.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2013Sterne AgeeBoost Price TargetBuy$8.50 -> $12.00ViewTweet This Rating  Share This Rating on StockTwits
1/22/2013Sterne AgeeReiterated RatingBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/20/2012 forward)